Clinical trial
Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH…
NCT00129402 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00129402 |
|---|---|
| Title | Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579) |
| Official title | Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia |
| Lead sponsor | Organon and Co, Industry |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | ezetimibe with simvastatin, simvastatin |
| Enrollment | 248 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Aug 11, 2005 |
| Last update posted | Feb 8, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: